Biblio
“Altered Expression of Circulating Cdc42 in Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1477-1483, 2018.
, “Altered Expression of Urea Cycle Enzymes in Amyloid-β Protein Precursor Overexpressing PC12 Cells and in Sporadic Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 62, no. 1, pp. 279-291, 2018.
, “Altered microRNA, mRNA, and Protein Expression of Neurodegeneration-Related Biomarkers and Their Transcriptional and Epigenetic Modifiers in a Human Tau Transgenic Mouse Model in Response to Developmental Lead Exposure.”, J Alzheimers Dis, vol. 63, no. 1, pp. 273-282, 2018.
, “Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 2, pp. 631-644, 2018.
, “Alzheimer's Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1495-1506, 2018.
, “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
, “Alzheimer's Disease: Advances in Drug Development.”, J Alzheimers Dis, vol. 65, no. 1, pp. 3-13, 2018.
, “The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.”, J Alzheimers Dis, vol. 63, no. 2, pp. 423-444, 2018.
, “Alzheimer's Disease Biomarkers Have Distinct Associations with Specific Hippocampal Subfield Volumes.”, J Alzheimers Dis, vol. 66, no. 2, pp. 811-823, 2018.
, “Alzheimer's Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1219-1222, 2018.
, “Alzheimer's Disease Computer-Aided Diagnosis: Histogram-Based Analysis of Regional MRI Volumes for Feature Selection and Classification.”, J Alzheimers Dis, vol. 65, no. 3, pp. 819-842, 2018.
, “Alzheimer's Disease in Systemic Sclerosis Patients: A Nationwide Population-Based Cohort Study.”, J Alzheimers Dis, vol. 65, no. 1, pp. 117-124, 2018.
, “Alzheimer's Disease, Oligomers, and Inflammation.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1261-1276, 2018.
, “Alzheimer's Disease Progression: Factors Influencing Cognitive Decline.”, J Alzheimers Dis, vol. 61, no. 2, pp. 785-791, 2018.
, “Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.”, J Alzheimers Dis, vol. 62, no. 2, pp. 523-547, 2018.
, “Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
, “Alzheimer's Disease, Visual Search, and Instrumental Activities of Daily Living: A Review and a New Perspective on Attention and Eye Movements.”, J Alzheimers Dis, vol. 66, no. 3, pp. 901-925, 2018.
, “Amsterdam Dementia Cohort: Performing Research to Optimize Care.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1091-1111, 2018.
, “Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S633-S646, 2018.
, “Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.”, J Alzheimers Dis, vol. 66, no. 1, pp. 307-318, 2018.
, “Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 525-532, 2018.
, “Amyloid-β and Tau in Alzheimer's Disease: Novel Pathomechanisms and Non-Pharmacological Treatment Strategies.”, J Alzheimers Dis, vol. 64, no. s1, pp. S517-S527, 2018.
, “Amyloid-β Induces AMPA Receptor Ubiquitination and Degradation in Primary Neurons and Human Brains of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1789-1801, 2018.
, “The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.”, J Alzheimers Dis, vol. 64, no. s1, pp. S567-S610, 2018.
, “Amyloid-β25-35 Upregulates Endogenous Neuroprotectant Neuroglobin via NFκB Activation in vitro.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1163-1174, 2018.
,